Ayurveda Market Size, Share & Trends Report

Ayurveda Market Size, Share & Trends Analysis Report By Form (Herbal), By Application (Personal), By Indication (Skin/Hair), By Distribution Channel (Direct Sales), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-263-0
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Ayurveda Form Outlook (Revenue, USD Million, 2018 - 2030)
- Herbal
- Mineral
- Herbomineral
Ayurveda Application Outlook (Revenue, USD Million, 2018 - 2030)
- Medical/Therapy
- Personal
Ayurveda Indications Outlook (Revenue, USD Million, 2018 - 2030)
- GI Tract
- Infectious Diseases
- Skin/Hair
- Respiratory System
- Nervous System
- Cardiovascular System
- Others
Ayurveda Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Direct Sales
- E-sales
- Distance Correspondence
Ayurveda End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Clinics
- Academia & Research
Ayurveda Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Form Outlook (Revenue in USD Million, 2018 - 2030)
    - Herbal
    - Mineral
    - Herbomineral
  - North America Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Medical/Therapy
    - Personal
  - North America Indication Outlook (Revenue in USD Million, 2018 - 2030)
    - GI tract
    - Infectious diseases
    - Skin/Hair
    - Respiratory system
    - Nervous system
    - Cardiovascular system
    - Others
  - North America Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Direct sales
    - E-sales
    - Distance correspondence
  - North America End-Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Hospitals
    - Clinics
    - Academia & research
  - U.S.
    - U.S. Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - U.S. Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - U.S. Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - U.S. End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Canada
    - Canada Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Canada Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Canada Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Canada Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Canada End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
- Europe
  - Europe Form Outlook (Revenue in USD Million, 2018 - 2030)
    - Herbal
    - Mineral
    - Herbomineral
  - Europe Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Medical/Therapy
    - Personal
  - Europe Indication Outlook (Revenue in USD Million, 2018 - 2030)
    - GI tract
    - Infectious diseases
    - Skin/Hair
    - Respiratory system
    - Nervous system
    - Cardiovascular system
    - Others
  - Europe Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Direct sales
    - E-sales
    - Distance correspondence
  - Europe End-Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Hospitals
    - Clinics
    - Academia & research
  - UK
    - UK Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - UK Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - UK Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - UK Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - UK End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Germany
    - Germany Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Germany Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Germany Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Germany Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Germany End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - France
    - France Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - France Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - France Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - France Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - France End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Italy
    - Italy Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Italy Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Italy Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Italy Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Italy End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Spain
    - Spain Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Spain Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Spain Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Spain Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Spain End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Denmark
    - Denmark Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Denmark Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Denmark Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Direct sales
      - E-sales
      - Distance correspondence
    - Denmark End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Sweden
    - Sweden Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Sweden Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Sweden Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Sweden Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Sweden End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Norway
    - Norway Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Norway Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Norway Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Norway Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Norway End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
- Asia Pacific
  - Asia Pacific Form Outlook (Revenue in USD Million, 2018 - 2030)
    - Herbal
    - Mineral
    - Herbomineral
  - Asia Pacific Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Medical/Therapy
    - Personal
  - Asia Pacific Indication Outlook (Revenue in USD Million, 2018 - 2030)
    - GI tract
    - Infectious diseases
    - Skin/Hair
    - Respiratory system
    - Nervous system
    - Cardiovascular system
    - Others
  - Asia Pacific Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Direct sales
    - E-sales
    - Distance correspondence
  - Asia Pacific End-Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Hospitals
    - Clinics
    - Academia & research
  - Japan
    - Japan Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Japan Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Japan Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Japan Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Japan End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - China
    - China Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - China Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - China Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - China Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - China End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - India
    - India Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - India Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - India Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - India Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - India End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Australia
    - Australia Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Australia Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Australia Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Australia Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Australia End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - South Korea
    - South Korea Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - South Korea Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - South Korea Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - South Korea Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - South Korea End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Thailand
    - Thailand Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Thailand Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Thailand Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Thailand Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Thailand End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
- Latin America
  - Latin America Form Outlook (Revenue in USD Million, 2018 - 2030)
    - Herbal
    - Mineral
    - Herbomineral
  - Latin America Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Medical/Therapy
    - Personal
  - Latin America Indication Outlook (Revenue in USD Million, 2018 - 2030)
    - GI tract
    - Infectious diseases
    - Skin/Hair
    - Respiratory system
    - Nervous system
    - Cardiovascular system
    - Others
  - Latin America Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Direct sales
    - E-sales
    - Distance correspondence
  - Latin America End-Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Hospitals
    - Clinics
    - Academia & research
  - Brazil
    - Brazil Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Brazil Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Brazil Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Brazil Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Brazil End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Mexico
    - Mexico Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Mexico Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Mexico Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Mexico Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Mexico End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Argentina
    - Argentina Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Argentina Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Argentina Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Argentina Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Argentina End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
- Middle East and Africa (MEA)
  - Middle East and Africa (MEA) Form Outlook (Revenue in USD Million, 2018 - 2030)
    - Herbal
    - Mineral
    - Herbomineral
  - Middle East and Africa (MEA) Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Medical/Therapy
    - Personal
  - Middle East and Africa (MEA) Indication Outlook (Revenue in USD Million, 2018 - 2030)
    - GI tract
    - Infectious diseases
    - Skin/Hair
    - Respiratory system
    - Nervous system
    - Cardiovascular system
    - Others
  - Middle East and Africa (MEA) Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
    - Direct sales
    - E-sales
    - Distance correspondence
  - Middle East and Africa (MEA) End-Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Hospitals
    - Clinics
    - Academia & research
  - South Africa
    - South Africa Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - South Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - South Africa Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - South Africa Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - South Africa End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - South Arabia
    - South Arabia Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - South Arabia Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - South Arabia Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - South Arabia Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - South Arabia End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - UAE
    - UAE Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - UAE Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - UAE Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - UAE Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - UAE End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research
  - Kuwait
    - Kuwait Form Outlook (Revenue in USD Million, 2018 - 2030)
      - Herbal
      - Mineral
      - Herbomineral
    - Kuwait Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Medical/Therapy
      - Personal
    - Kuwait Indication Outlook (Revenue in USD Million, 2018 - 2030)
      - GI tract
      - Infectious diseases
      - Skin/Hair
      - Respiratory system
      - Nervous system
      - Cardiovascular system
      - Others
    - Kuwait Distribution Channel Outlook (Revenue in USD Million, 2018 - 2030)
      - Direct sales
      - E-sales
      - Distance correspondence
    - Kuwait End-Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Hospitals
      - Clinics
      - Academia & research

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.